MARKET

IVA

IVA

Inventiva S.A.
NASDAQ
2.905
-0.138
-4.54%
Closed 15:27 03/28 EDT
OPEN
3.010
PREV CLOSE
3.043
HIGH
3.010
LOW
2.890
VOLUME
3.31K
TURNOVER
--
52 WEEK HIGH
3.980
52 WEEK LOW
1.530
MARKET CAP
275.86M
P/E (TTM)
-0.9061
1D
5D
1M
3M
1Y
5Y
1D
Inventiva Price Target Maintained With a $13.00/Share by HC Wainwright & Co.
Dow Jones · 1d ago
Inventiva’s Strategic Positioning and Clinical Progress Drive Buy Rating Amid Promising MASH Therapy Developments
TipRanks · 1d ago
HC Wainwright & Co. Reiterates Buy on Inventiva, Maintains $13 Price Target
Benzinga · 1d ago
Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates
TipRanks · 1d ago
Promising Developments and Financial Outlook Propel Inventiva’s Phase III NATiV3 Trial Forward
TipRanks · 2d ago
BRIEF-Inventiva Reports Its 2024 Full Year Results And Provides A Business Update
Reuters · 3d ago
Inventiva Reports 2024 Financial Results and Strategic Shift
TipRanks · 3d ago
Inventiva S.A GAAP EPS of -€3.08 misses by €1.27, revenue of €9.19M beats by €1.88M
Seeking Alpha · 3d ago
More
About IVA
More
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
Recently
Symbol
Price
%Change

Webull offers Inventiva SA stock information, including NASDAQ: IVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IVA stock methods without spending real money on the virtual paper trading platform.